It is a pharma public limited company based in Vishakhapatnam, Andhra Pradesh, India, established in 2013.
2013 | Vishakhapatnam, Andhra Pradesh, India | ActiveNeopride Pharmaceuticals Limited, a active public limited company, was established on 26 March 2013 in Vishakhapatnam, Andhra Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74140AP2013PLC086653. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.55 Cr.
It upholds a compliant status. Its leadership includes Goluguri Ramakrishna Reddy (Director), Goluguri Sri Rama Reddy (Director), Goluguri Venkata Reddy (Director). Past directors included Raja Sekhara Reddy Tetali. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at H.No. 48-15-7, Sai Paradise Apartments Srinagar, Dwaraka Nagar, Vishakhapatnam, Andhra Pradesh, 530016.
U74140AP2013PLC086653
086653
26 March 2013
₹5.00 Cr
₹4.55 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Neopride Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Goluguri Ramakrishna Reddy | Director | 26 Mar 2013 | Current |
| Goluguri Sri Rama Reddy | Director | 26 Mar 2013 | Current |
| Goluguri Venkata Reddy | Director | 26 Mar 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Jul 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neopride Pharmaceuticals Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
|
In 2019, Neopride Pharmaceuticals had a promoter holding of 1.10% and a public holding of 98.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Neopride Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neopride Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neopride Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Neopride Pharmaceuticals Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
Progress on Neopride Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Vijayawada. was documented.
The activity Goluguri Ramakrishna Reddy was appointed as a Director was appointed as a Director on 26 Mar 2013 & has been associated with this company since 12 years 8 months . was completed.
The activity Goluguri Sri Rama Reddy was appointed as a Director was appointed as a Director on 26 Mar 2013 & has been associated with this company since 12 years 8 months . was completed.
The activity Goluguri Venkata Reddy was appointed as a Director was appointed as a Director on 26 Mar 2013 & has been associated with this company since 12 years 8 months . was completed.
Progress on Neopride Pharmaceuticals Limited was registered on 26 Mar 2013 with Roc Vijayawada & aged 12 years 8 months as per MCA records. was documented.
The CIN of Neopride Pharmaceuticals Limited is U74140AP2013PLC086653.
Neopride Pharmaceuticals Limited is headquartered at H.No. 48-15-7, Sai Paradise Apartments Srinagar, Dwaraka Nagar, Vishakhapatnam, Andhra Pradesh, 530016.
Neopride Pharmaceuticals Limited was incorporated on 26 March 2013.
The current directors of Neopride Pharmaceuticals Limited are
The primary industry of Neopride Pharmaceuticals Limited is Pharma.
Neopride Pharmaceuticals Limited is unlisted.
The authorized capital of Neopride Pharmaceuticals Limited is ₹5.00 Cr, and the paid-up capital is ₹4.55 Cr.
The compliance status of Neopride Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX